Published in
Springer, Cancer Immunology, Immunotherapy, 8(68), p. 1351-1358, 2019
DOI: 10.1007/s00262-019-02367-z
Links
Tools
Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study
Journal article published in 2019 by
Aldo Bonaventura 
,
Francesco Grossi ,
Federico Carbone ,
Alessandra Vecchié ,
Silvia Minetti,
Nicholas Bardi,
Edoardo Elia,
Anna Maria Ansaldo,
Daniele Ferrara,
Erika Rijavec,
Maria Giovanna Dal Bello,
Giovanni Rossi ,
Federica Biello ,
Marco Tagliamento ,
Angela Alama
and other authors.
,
Francesco Grossi ,
Federico Carbone ,
Alessandra Vecchié ,
Silvia Minetti,
Nicholas Bardi,
Edoardo Elia,
Anna Maria Ansaldo,
Daniele Ferrara,
Erika Rijavec,
Maria Giovanna Dal Bello,
Giovanni Rossi ,
Federica Biello ,
Marco Tagliamento ,
Angela Alama
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 